tiprankstipranks
Trending News
More News >

Eledon Pharma Adjusts CEO Bonus Structure

Story Highlights
Eledon Pharma Adjusts CEO Bonus Structure

Confident Investing Starts Here:

Eledon Pharmaceuticals ( (ELDN) ) has issued an update.

Eledon Pharmaceuticals announced an amendment to the employment agreement of its CEO, David-Alexandre Gros, adjusting the market value cap for his performance bonus. The CEO’s bonus structure has been altered, allowing for a maximum bonus of $15 million if the company’s market value reaches $1.5 billion, with linear interpolation determining payouts between set thresholds.

More about Eledon Pharmaceuticals

YTD Price Performance: 134.44%

Average Trading Volume: 491,893

Technical Sentiment Consensus Rating: Sell

Current Market Cap: $252.1M

For detailed information about ELDN stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App